Physician Supervised Weight Loss

At your consult, Dr. Patel will individually tailor a weight loss program using WeGovy  (also sold as Ozempic) to help you lose weight. Weight loss in this manor has been proven to be effective in helping individuals reach their weight goals.  Our patients who have gone through this program note increased energy levels, improved self-esteem, improved blood sugar and cholesterol levels, decreased joint and back pain, improved sleep, and an overall sense of wellbeing!

What is WeGovy?

WeGovy, also called semaglutide, is an FDA-approved once-weekly subcutaneous (under the skin) weight loss injection.

Semaglutide (Ozempic) has been around for many years to help diabetic patients control their blood sugar levels. In this same study, this medication was also found to reduce weight.  Since diabetic patients started losing weight on semaglutide, it was studied to be used as a weight-loss injectable medication. Since June 2021, semaglutide under the brand name Wegovy was FDA approved for long-term weight loss.

Semaglutide is 94% similar to natural human glucagon-like peptide 1 (GLP-1), which decreases blood sugar levels in a glucose-dependent manner by enhancing the secretion of insulin. GLP-1 acts as a physiological regulator of appetite and thereby reducing food intake by reducing feelings of hunger and increasing feelings of fullness/satiety.

What are common side effects? 

The most common side effecs when starting with WeGovy are related to the gut, typically patients feel nauseated and some even vomit.  Soon after starting, typically side effects are minimal. Patient's not that with 3 or more weeks of therapy they have:

• Suppressed appetite
• Boost in energy
• Increased metabolism
• Promotion of fat-burning
• Lower cholesterol

What packages are avaiable?

Patients can choose to receive semaglutide for only 1 week as a trial or 4, 8, and 12 week packages. Please be advised that semaglutide is dose-dependent upon the duration of use- meaning the longer you use it, the higher your dose will be up to 2.4mg/week.